Items where authors include "Cresswell, J"

Article

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Mostafid, AH, Porta, N, Cresswell, J et al. (14 more authors) (2020) CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin‐C vs surgical management in low‐risk non‐muscle‐invasive bladder cancer. BJU International, 125 (6). pp. 817-826. ISSN 1464-4096

Tan, WS, Sarpong, R, Khetrapal, P et al. (16 more authors) (2019) Does urinary cytology have a role in haematuria investigations? BJU International, 123 (1). pp. 74-81. ISSN 1464-4096

Conference or Workshop Item

Huddart, RA, Lewis, R, Griffin, C et al. (17 more authors) (2020) Patterns of use of chemotherapy with radiotherapy in the treatment of muscle-invasive bladder cancer: Data from the RAIDER randomized trial of adaptive radiotherapy. In: 2020 Genitourinary Cancers Symposium, 13-15 Feb 2020, San Francisco, CA, USA.